XML 164 R52.htm IDEA: XBRL DOCUMENT v3.21.2
Segmental information - Consolidated income statement (Details) - GBP (£)
£ in Millions
 12 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2019
Disclosure of operating segments [line items]      
Sales £ 19,153 £ 17,697 £ 19,294
Net sales      
At budgeted exchange rates 13,483 11,579 12,424
Acquisitions and disposals 35 93 92
SC&P allocation 0 0 0
Retranslation to actual exchange rates (785) 80 351
Net sales 12,733 11,752 12,867
Operating profit/(loss)      
At budgeted exchange rates 4,160 3,498 3,920
Acquisitions and disposals (21) (5) 28
SC&P allocation 0 0 0
Fair value remeasurement of contingent considerations, equity option and earn out arrangements (36)    
Fair value remeasurement of contingent consideration   (7)  
Fair value remeasurement of biological assets 0 9  
Retranslation to actual exchange rates (357) (1) 168
Operating profit/(loss) before exceptional items 3,746 3,494 4,116
Exceptional items (15) (1,357) (74)
Operating profit/(loss) 3,731 2,137 4,042
Non-operating items 14 (23) 144
Net finance charges (373) (353) (263)
Share of after tax results of associates and joint ventures      
Share of after tax results of associates and joint ventures 334 282 312
Profit before taxation £ 3,706 2,043 4,235
Annual net sales occur in the last four months 40.00%    
Moet Hennessy      
Net sales      
Net sales £ 4,819 4,425 4,713
Share of after tax results of associates and joint ventures      
Share of after tax results of associates and joint ventures 335 285 310
Other      
Share of after tax results of associates and joint ventures      
Share of after tax results of associates and joint ventures (1) (3) 2
Operating segments      
Disclosure of operating segments [line items]      
Sales 19,133 17,659 19,241
Net sales      
At budgeted exchange rates 13,463 11,541 12,370
Acquisitions and disposals 35 93 92
SC&P allocation 0 (1) 0
Retranslation to actual exchange rates (785) 81 352
Net sales 12,713 11,714 12,814
Operating profit/(loss)      
At budgeted exchange rates 4,378 3,650 4,106
Acquisitions and disposals (21) (5) 28
SC&P allocation 0 0 0
Fair value remeasurement of contingent considerations, equity option and earn out arrangements (36)    
Fair value remeasurement of contingent consideration   (7)  
Fair value remeasurement of biological assets 0 9  
Retranslation to actual exchange rates (367) (6) 171
Operating profit/(loss) before exceptional items 3,954 3,641 4,305
Exceptional items (15) (1,357) (53)
Operating profit/(loss) 3,939 2,284 4,252
Operating segments | North America      
Disclosure of operating segments [line items]      
Sales 5,803 5,222 5,074
Net sales      
At budgeted exchange rates 5,527 4,445 4,034
Acquisitions and disposals 28 32 88
SC&P allocation 9 11 11
Retranslation to actual exchange rates (355) 135 327
Net sales 5,209 4,623 4,460
Operating profit/(loss)      
At budgeted exchange rates 2,469 2,007 1,755
Acquisitions and disposals (18) (1) 29
SC&P allocation (30) 6 13
Fair value remeasurement of contingent considerations, equity option and earn out arrangements (9)    
Fair value remeasurement of contingent consideration   (10)  
Fair value remeasurement of biological assets 0 0  
Retranslation to actual exchange rates (175) 32 151
Operating profit/(loss) before exceptional items 2,237 2,034 1,948
Exceptional items 0 54 0
Operating profit/(loss) 2,237 2,088 1,948
Operating segments | Europe and Turkey      
Disclosure of operating segments [line items]      
Sales 4,795 4,697 5,132
Net sales      
At budgeted exchange rates 2,579 2,501 2,951
Acquisitions and disposals 2 10 1
SC&P allocation 45 60 63
Retranslation to actual exchange rates (68) (4) (76)
Net sales 2,558 2,567 2,939
Operating profit/(loss)      
At budgeted exchange rates 728 730 972
Acquisitions and disposals (3) (4) (1)
SC&P allocation (32) 26 72
Fair value remeasurement of contingent considerations, equity option and earn out arrangements (27)    
Fair value remeasurement of contingent consideration   (4)  
Fair value remeasurement of biological assets 0 0  
Retranslation to actual exchange rates (31) 9 (29)
Operating profit/(loss) before exceptional items 635 757 1,014
Exceptional items (15) (62) (18)
Operating profit/(loss) 620 695 996
Operating segments | Africa      
Disclosure of operating segments [line items]      
Sales 2,020 1,911 2,235
Net sales      
At budgeted exchange rates 1,541 1,300 1,529
Acquisitions and disposals 5 50 1
SC&P allocation 3 4 5
Retranslation to actual exchange rates (137) (8) 62
Net sales 1,412 1,346 1,597
Operating profit/(loss)      
At budgeted exchange rates 228 116 257
Acquisitions and disposals 0 0 0
SC&P allocation (3) 2 6
Fair value remeasurement of contingent considerations, equity option and earn out arrangements 0    
Fair value remeasurement of contingent consideration   0  
Fair value remeasurement of biological assets 0 0  
Retranslation to actual exchange rates (54) (17) 12
Operating profit/(loss) before exceptional items 171 101 275
Exceptional items 0 (145) 0
Operating profit/(loss) 171 (44) 275
Operating segments | Latin America and Caribbean      
Disclosure of operating segments [line items]      
Sales 1,369 1,184 1,444
Net sales      
At budgeted exchange rates 1,176 944 1,095
Acquisitions and disposals 0 0 1
SC&P allocation 13 10 15
Retranslation to actual exchange rates (143) (46) 19
Net sales 1,046 908 1,130
Operating profit/(loss)      
At budgeted exchange rates 422 254 312
Acquisitions and disposals 0 0 0
SC&P allocation (27) 5 32
Fair value remeasurement of contingent considerations, equity option and earn out arrangements 0    
Fair value remeasurement of contingent consideration   7  
Fair value remeasurement of biological assets 0 9  
Retranslation to actual exchange rates (92) (27) 21
Operating profit/(loss) before exceptional items 303 248 365
Exceptional items 0 (6) 0
Operating profit/(loss) 303 242 365
Operating segments | Asia Pacific      
Disclosure of operating segments [line items]      
Sales 5,146 4,645 5,356
Net sales      
At budgeted exchange rates 2,561 2,253 2,656
Acquisitions and disposals 0 1 1
SC&P allocation 9 12 11
Retranslation to actual exchange rates (82) 4 20
Net sales 2,488 2,270 2,688
Operating profit/(loss)      
At budgeted exchange rates 628 498 671
Acquisitions and disposals 0 0 0
SC&P allocation (5) 6 16
Fair value remeasurement of contingent considerations, equity option and earn out arrangements 0    
Fair value remeasurement of contingent consideration   0  
Fair value remeasurement of biological assets 0 0  
Retranslation to actual exchange rates (15) (3) 16
Operating profit/(loss) before exceptional items 608 501 703
Exceptional items 0 (1,198) (35)
Operating profit/(loss) 608 (697) 668
Operating segments | SC&P      
Disclosure of operating segments [line items]      
Sales 1,537 1,343 1,739
Net sales      
At budgeted exchange rates 1,627 1,439 1,843
Acquisitions and disposals 0 0 0
SC&P allocation (79) (98) (105)
Retranslation to actual exchange rates (11) 2 1
Net sales 1,537 1,343 1,739
Operating profit/(loss)      
At budgeted exchange rates (97) 45 139
Acquisitions and disposals 0 0 0
SC&P allocation 97 (45) (139)
Fair value remeasurement of contingent considerations, equity option and earn out arrangements 0    
Fair value remeasurement of contingent consideration   0  
Fair value remeasurement of biological assets 0 0  
Retranslation to actual exchange rates 0 0 0
Operating profit/(loss) before exceptional items 0 0 0
Exceptional items 0 0 0
Operating profit/(loss) 0 0 0
Elimination of intersegment sales      
Disclosure of operating segments [line items]      
Sales (1,537) (1,343) (1,739)
Net sales      
At budgeted exchange rates (1,548) (1,341) (1,738)
Acquisitions and disposals 0 0 0
SC&P allocation 0 0 0
Retranslation to actual exchange rates 11 (2) (1)
Net sales (1,537) (1,343) (1,739)
Corporate and other      
Disclosure of operating segments [line items]      
Sales 20 38 53
Net sales      
At budgeted exchange rates 20 38 54
Acquisitions and disposals 0 0 0
SC&P allocation 0 1 0
Retranslation to actual exchange rates 0 (1) (1)
Net sales 20 38 53
Operating profit/(loss)      
At budgeted exchange rates (218) (152) (186)
Acquisitions and disposals 0 0 0
SC&P allocation 0 0 0
Fair value remeasurement of contingent considerations, equity option and earn out arrangements 0    
Fair value remeasurement of contingent consideration   0  
Fair value remeasurement of biological assets 0 0  
Retranslation to actual exchange rates 10 5 (3)
Operating profit/(loss) before exceptional items (208) (147) (189)
Exceptional items 0 0 (21)
Operating profit/(loss) £ (208) £ (147) £ (210)